The global market for Rabies Vaccine for Humans was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Rabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus.

There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies, before or after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rabies Vaccine for Humans, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rabies Vaccine for Humans.

The Rabies Vaccine for Humans market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rabies Vaccine for Humans market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Rabies Vaccine for Humans manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Rabies Vaccine for Humans Market Report

Report Metric	Details
Report Name	Rabies Vaccine for Humans Market
CAGR	5%
Segment by Type	Preventative Vaccine Emergency Rabies Vaccine
Segment by Application	Pre-exposure prophylaxis Post-exposure prophylaxis
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Novartis, Sanofi, GlaxoSmithKline, Merck, Chengda, Yisheng, Prcmise, VACN, Changsheng, BCHT, Hissen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rabies Vaccine for Humans manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rabies Vaccine for Humans in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Rabies Vaccine for Humans Market report?

Ans: The main players in the Rabies Vaccine for Humans Market are Novartis, Sanofi, GlaxoSmithKline, Merck, Chengda, Yisheng, Prcmise, VACN, Changsheng, BCHT, Hissen

What are the Application segmentation covered in the Rabies Vaccine for Humans Market report?

Ans: The Applications covered in the Rabies Vaccine for Humans Market report are Pre-exposure prophylaxis, Post-exposure prophylaxis

What are the Type segmentation covered in the Rabies Vaccine for Humans Market report?

Ans: The Types covered in the Rabies Vaccine for Humans Market report are Preventative Vaccine, Emergency Rabies Vaccine

1 Rabies Vaccine for Humans Market Overview

1.1 Product Definition

1.2 Rabies Vaccine for Humans by Type

1.2.1 Global Rabies Vaccine for Humans Market Value Comparison by Type (2024 VS 2031)

1.2.2 Preventative Vaccine

1.2.3 Emergency Rabies Vaccine

1.3 Rabies Vaccine for Humans by Application

1.3.1 Global Rabies Vaccine for Humans Market Value by Application (2024 VS 2031)

1.3.2 Pre-exposure prophylaxis

1.3.3 Post-exposure prophylaxis

1.4 Global Rabies Vaccine for Humans Market Size Estimates and Forecasts

1.4.1 Global Rabies Vaccine for Humans Revenue 2020-2031

1.4.2 Global Rabies Vaccine for Humans Sales 2020-2031

1.4.3 Global Rabies Vaccine for Humans Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Rabies Vaccine for Humans Market Competition by Manufacturers

2.1 Global Rabies Vaccine for Humans Sales Market Share by Manufacturers (2020-2025)

2.2 Global Rabies Vaccine for Humans Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Rabies Vaccine for Humans Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Rabies Vaccine for Humans, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Rabies Vaccine for Humans, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Rabies Vaccine for Humans, Product Type & Application

2.7 Global Key Manufacturers of Rabies Vaccine for Humans, Date of Enter into This Industry

2.8 Global Rabies Vaccine for Humans Market Competitive Situation and Trends

2.8.1 Global Rabies Vaccine for Humans Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Rabies Vaccine for Humans Players Market Share by Revenue

2.8.3 Global Rabies Vaccine for Humans Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Rabies Vaccine for Humans Market Scenario by Region

3.1 Global Rabies Vaccine for Humans Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Rabies Vaccine for Humans Sales by Region: 2020-2031

3.2.1 Global Rabies Vaccine for Humans Sales by Region: 2020-2025

3.2.2 Global Rabies Vaccine for Humans Sales by Region: 2026-2031

3.3 Global Rabies Vaccine for Humans Revenue by Region: 2020-2031

3.3.1 Global Rabies Vaccine for Humans Revenue by Region: 2020-2025

3.3.2 Global Rabies Vaccine for Humans Revenue by Region: 2026-2031

3.4 North America Rabies Vaccine for Humans Market Facts & Figures by Country

3.4.1 North America Rabies Vaccine for Humans Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Rabies Vaccine for Humans Sales by Country (2020-2031)

3.4.3 North America Rabies Vaccine for Humans Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Rabies Vaccine for Humans Market Facts & Figures by Country

3.5.1 Europe Rabies Vaccine for Humans Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Rabies Vaccine for Humans Sales by Country (2020-2031)

3.5.3 Europe Rabies Vaccine for Humans Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Rabies Vaccine for Humans Market Facts & Figures by Region

3.6.1 Asia Pacific Rabies Vaccine for Humans Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Rabies Vaccine for Humans Sales by Region (2020-2031)

3.6.3 Asia Pacific Rabies Vaccine for Humans Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Rabies Vaccine for Humans Market Facts & Figures by Country

3.7.1 Latin America Rabies Vaccine for Humans Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Rabies Vaccine for Humans Sales by Country (2020-2031)

3.7.3 Latin America Rabies Vaccine for Humans Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Rabies Vaccine for Humans Market Facts & Figures by Country

3.8.1 Middle East and Africa Rabies Vaccine for Humans Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Rabies Vaccine for Humans Sales by Country (2020-2031)

3.8.3 Middle East and Africa Rabies Vaccine for Humans Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Rabies Vaccine for Humans Sales by Type (2020-2031)

4.1.1 Global Rabies Vaccine for Humans Sales by Type (2020-2025)

4.1.2 Global Rabies Vaccine for Humans Sales by Type (2026-2031)

4.1.3 Global Rabies Vaccine for Humans Sales Market Share by Type (2020-2031)

4.2 Global Rabies Vaccine for Humans Revenue by Type (2020-2031)

4.2.1 Global Rabies Vaccine for Humans Revenue by Type (2020-2025)

4.2.2 Global Rabies Vaccine for Humans Revenue by Type (2026-2031)

4.2.3 Global Rabies Vaccine for Humans Revenue Market Share by Type (2020-2031)

4.3 Global Rabies Vaccine for Humans Price by Type (2020-2031)

5 Segment by Application

5.1 Global Rabies Vaccine for Humans Sales by Application (2020-2031)

5.1.1 Global Rabies Vaccine for Humans Sales by Application (2020-2025)

5.1.2 Global Rabies Vaccine for Humans Sales by Application (2026-2031)

5.1.3 Global Rabies Vaccine for Humans Sales Market Share by Application (2020-2031)

5.2 Global Rabies Vaccine for Humans Revenue by Application (2020-2031)

5.2.1 Global Rabies Vaccine for Humans Revenue by Application (2020-2025)

5.2.2 Global Rabies Vaccine for Humans Revenue by Application (2026-2031)

5.2.3 Global Rabies Vaccine for Humans Revenue Market Share by Application (2020-2031)

5.3 Global Rabies Vaccine for Humans Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Novartis

6.1.1 Novartis Company Information

6.1.2 Novartis Description and Business Overview

6.1.3 Novartis Rabies Vaccine for Humans Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Novartis Rabies Vaccine for Humans Product Portfolio

6.1.5 Novartis Recent Developments/Updates

6.2 Sanofi

6.2.1 Sanofi Company Information

6.2.2 Sanofi Description and Business Overview

6.2.3 Sanofi Rabies Vaccine for Humans Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Sanofi Rabies Vaccine for Humans Product Portfolio

6.2.5 Sanofi Recent Developments/Updates

6.3 GlaxoSmithKline

6.3.1 GlaxoSmithKline Company Information

6.3.2 GlaxoSmithKline Description and Business Overview

6.3.3 GlaxoSmithKline Rabies Vaccine for Humans Sales, Revenue and Gross Margin (2020-2025)

6.3.4 GlaxoSmithKline Rabies Vaccine for Humans Product Portfolio

6.3.5 GlaxoSmithKline Recent Developments/Updates

6.4 Merck

6.4.1 Merck Company Information

6.4.2 Merck Description and Business Overview

6.4.3 Merck Rabies Vaccine for Humans Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Merck Rabies Vaccine for Humans Product Portfolio

6.4.5 Merck Recent Developments/Updates

6.5 Chengda

6.5.1 Chengda Company Information

6.5.2 Chengda Description and Business Overview

6.5.3 Chengda Rabies Vaccine for Humans Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Chengda Rabies Vaccine for Humans Product Portfolio

6.5.5 Chengda Recent Developments/Updates

6.6 Yisheng

6.6.1 Yisheng Company Information

6.6.2 Yisheng Description and Business Overview

6.6.3 Yisheng Rabies Vaccine for Humans Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Yisheng Rabies Vaccine for Humans Product Portfolio

6.6.5 Yisheng Recent Developments/Updates

6.7 Prcmise

6.7.1 Prcmise Company Information

6.7.2 Prcmise Description and Business Overview

6.7.3 Prcmise Rabies Vaccine for Humans Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Prcmise Rabies Vaccine for Humans Product Portfolio

6.7.5 Prcmise Recent Developments/Updates

6.8 VACN

6.8.1 VACN Company Information

6.8.2 VACN Description and Business Overview

6.8.3 VACN Rabies Vaccine for Humans Sales, Revenue and Gross Margin (2020-2025)

6.8.4 VACN Rabies Vaccine for Humans Product Portfolio

6.8.5 VACN Recent Developments/Updates

6.9 Changsheng

6.9.1 Changsheng Company Information

6.9.2 Changsheng Description and Business Overview

6.9.3 Changsheng Rabies Vaccine for Humans Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Changsheng Rabies Vaccine for Humans Product Portfolio

6.9.5 Changsheng Recent Developments/Updates

6.10 BCHT

6.10.1 BCHT Company Information

6.10.2 BCHT Description and Business Overview

6.10.3 BCHT Rabies Vaccine for Humans Sales, Revenue and Gross Margin (2020-2025)

6.10.4 BCHT Rabies Vaccine for Humans Product Portfolio

6.10.5 BCHT Recent Developments/Updates

6.11 Hissen

6.11.1 Hissen Company Information

6.11.2 Hissen Description and Business Overview

6.11.3 Hissen Rabies Vaccine for Humans Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Hissen Rabies Vaccine for Humans Product Portfolio

6.11.5 Hissen Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Rabies Vaccine for Humans Industry Chain Analysis

7.2 Rabies Vaccine for Humans Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Rabies Vaccine for Humans Production Mode & Process Analysis

7.4 Rabies Vaccine for Humans Sales and Marketing

7.4.1 Rabies Vaccine for Humans Sales Channels

7.4.2 Rabies Vaccine for Humans Distributors

7.5 Rabies Vaccine for Humans Customer Analysis

8 Rabies Vaccine for Humans Market Dynamics

8.1 Rabies Vaccine for Humans Industry Trends

8.2 Rabies Vaccine for Humans Market Drivers

8.3 Rabies Vaccine for Humans Market Challenges

8.4 Rabies Vaccine for Humans Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Rabies Vaccine for Humans Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Rabies Vaccine for Humans Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Rabies Vaccine for Humans Market Competitive Situation by Manufacturers in 2024

Table 4. Global Rabies Vaccine for Humans Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Rabies Vaccine for Humans Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Rabies Vaccine for Humans Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Rabies Vaccine for Humans Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Rabies Vaccine for Humans Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Rabies Vaccine for Humans, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Rabies Vaccine for Humans, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Rabies Vaccine for Humans, Product Type & Application

Table 12. Global Key Manufacturers of Rabies Vaccine for Humans, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Rabies Vaccine for Humans by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Vaccine for Humans as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Rabies Vaccine for Humans Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Rabies Vaccine for Humans Sales by Region (2020-2025) & (K Units)

Table 18. Global Rabies Vaccine for Humans Sales Market Share by Region (2020-2025)

Table 19. Global Rabies Vaccine for Humans Sales by Region (2026-2031) & (K Units)

Table 20. Global Rabies Vaccine for Humans Sales Market Share by Region (2026-2031)

Table 21. Global Rabies Vaccine for Humans Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Rabies Vaccine for Humans Revenue Market Share by Region (2020-2025)

Table 23. Global Rabies Vaccine for Humans Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Rabies Vaccine for Humans Revenue Market Share by Region (2026-2031)

Table 25. North America Rabies Vaccine for Humans Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Rabies Vaccine for Humans Sales by Country (2020-2025) & (K Units)

Table 27. North America Rabies Vaccine for Humans Sales by Country (2026-2031) & (K Units)

Table 28. North America Rabies Vaccine for Humans Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Rabies Vaccine for Humans Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Rabies Vaccine for Humans Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Rabies Vaccine for Humans Sales by Country (2020-2025) & (K Units)

Table 32. Europe Rabies Vaccine for Humans Sales by Country (2026-2031) & (K Units)

Table 33. Europe Rabies Vaccine for Humans Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Rabies Vaccine for Humans Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Rabies Vaccine for Humans Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Rabies Vaccine for Humans Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Rabies Vaccine for Humans Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Rabies Vaccine for Humans Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Rabies Vaccine for Humans Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Rabies Vaccine for Humans Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Rabies Vaccine for Humans Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Rabies Vaccine for Humans Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Rabies Vaccine for Humans Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Rabies Vaccine for Humans Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Rabies Vaccine for Humans Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Rabies Vaccine for Humans Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Rabies Vaccine for Humans Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Rabies Vaccine for Humans Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Rabies Vaccine for Humans Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Rabies Vaccine for Humans Sales (K Units) by Type (2020-2025)

Table 51. Global Rabies Vaccine for Humans Sales (K Units) by Type (2026-2031)

Table 52. Global Rabies Vaccine for Humans Sales Market Share by Type (2020-2025)

Table 53. Global Rabies Vaccine for Humans Sales Market Share by Type (2026-2031)

Table 54. Global Rabies Vaccine for Humans Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Rabies Vaccine for Humans Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Rabies Vaccine for Humans Revenue Market Share by Type (2020-2025)

Table 57. Global Rabies Vaccine for Humans Revenue Market Share by Type (2026-2031)

Table 58. Global Rabies Vaccine for Humans Price (USD/Unit) by Type (2020-2025)

Table 59. Global Rabies Vaccine for Humans Price (USD/Unit) by Type (2026-2031)

Table 60. Global Rabies Vaccine for Humans Sales (K Units) by Application (2020-2025)

Table 61. Global Rabies Vaccine for Humans Sales (K Units) by Application (2026-2031)

Table 62. Global Rabies Vaccine for Humans Sales Market Share by Application (2020-2025)

Table 63. Global Rabies Vaccine for Humans Sales Market Share by Application (2026-2031)

Table 64. Global Rabies Vaccine for Humans Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Rabies Vaccine for Humans Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Rabies Vaccine for Humans Revenue Market Share by Application (2020-2025)

Table 67. Global Rabies Vaccine for Humans Revenue Market Share by Application (2026-2031)

Table 68. Global Rabies Vaccine for Humans Price (USD/Unit) by Application (2020-2025)

Table 69. Global Rabies Vaccine for Humans Price (USD/Unit) by Application (2026-2031)

Table 70. Novartis Company Information

Table 71. Novartis Description and Business Overview

Table 72. Novartis Rabies Vaccine for Humans Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Novartis Rabies Vaccine for Humans Product

Table 74. Novartis Recent Developments/Updates

Table 75. Sanofi Company Information

Table 76. Sanofi Description and Business Overview

Table 77. Sanofi Rabies Vaccine for Humans Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Sanofi Rabies Vaccine for Humans Product

Table 79. Sanofi Recent Developments/Updates

Table 80. GlaxoSmithKline Company Information

Table 81. GlaxoSmithKline Description and Business Overview

Table 82. GlaxoSmithKline Rabies Vaccine for Humans Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. GlaxoSmithKline Rabies Vaccine for Humans Product

Table 84. GlaxoSmithKline Recent Developments/Updates

Table 85. Merck Company Information

Table 86. Merck Description and Business Overview

Table 87. Merck Rabies Vaccine for Humans Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Merck Rabies Vaccine for Humans Product

Table 89. Merck Recent Developments/Updates

Table 90. Chengda Company Information

Table 91. Chengda Description and Business Overview

Table 92. Chengda Rabies Vaccine for Humans Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Chengda Rabies Vaccine for Humans Product

Table 94. Chengda Recent Developments/Updates

Table 95. Yisheng Company Information

Table 96. Yisheng Description and Business Overview

Table 97. Yisheng Rabies Vaccine for Humans Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Yisheng Rabies Vaccine for Humans Product

Table 99. Yisheng Recent Developments/Updates

Table 100. Prcmise Company Information

Table 101. Prcmise Description and Business Overview

Table 102. Prcmise Rabies Vaccine for Humans Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Prcmise Rabies Vaccine for Humans Product

Table 104. Prcmise Recent Developments/Updates

Table 105. VACN Company Information

Table 106. VACN Description and Business Overview

Table 107. VACN Rabies Vaccine for Humans Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. VACN Rabies Vaccine for Humans Product

Table 109. VACN Recent Developments/Updates

Table 110. Changsheng Company Information

Table 111. Changsheng Description and Business Overview

Table 112. Changsheng Rabies Vaccine for Humans Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Changsheng Rabies Vaccine for Humans Product

Table 114. Changsheng Recent Developments/Updates

Table 115. BCHT Company Information

Table 116. BCHT Description and Business Overview

Table 117. BCHT Rabies Vaccine for Humans Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. BCHT Rabies Vaccine for Humans Product

Table 119. BCHT Recent Developments/Updates

Table 120. Hissen Company Information

Table 121. Hissen Description and Business Overview

Table 122. Hissen Rabies Vaccine for Humans Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 123. Hissen Rabies Vaccine for Humans Product

Table 124. Hissen Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Rabies Vaccine for Humans Distributors List

Table 128. Rabies Vaccine for Humans Customers List

Table 129. Rabies Vaccine for Humans Market Trends

Table 130. Rabies Vaccine for Humans Market Drivers

Table 131. Rabies Vaccine for Humans Market Challenges

Table 132. Rabies Vaccine for Humans Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Product Picture of Rabies Vaccine for Humans

Figure 2. Global Rabies Vaccine for Humans Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Rabies Vaccine for Humans Market Share by Type: 2024 & 2031

Figure 4. Preventative Vaccine Product Picture

Figure 5. Emergency Rabies Vaccine Product Picture

Figure 6. Global Rabies Vaccine for Humans Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Rabies Vaccine for Humans Market Share by Application: 2024 & 2031

Figure 8. Pre-exposure prophylaxis

Figure 9. Post-exposure prophylaxis

Figure 10. Global Rabies Vaccine for Humans Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Rabies Vaccine for Humans Market Size (2020-2031) & (US$ Million)

Figure 12. Global Rabies Vaccine for Humans Sales (2020-2031) & (K Units)

Figure 13. Global Rabies Vaccine for Humans Average Price (USD/Unit) & (2020-2031)

Figure 14. Rabies Vaccine for Humans Report Years Considered

Figure 15. Rabies Vaccine for Humans Sales Share by Manufacturers in 2024

Figure 16. Global Rabies Vaccine for Humans Revenue Share by Manufacturers in 2024

Figure 17. Global 5 and 10 Largest Rabies Vaccine for Humans Players: Market Share by Revenue in Rabies Vaccine for Humans in 2024

Figure 18. Rabies Vaccine for Humans Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. Global Rabies Vaccine for Humans Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 20. North America Rabies Vaccine for Humans Sales Market Share by Country (2020-2031)

Figure 21. North America Rabies Vaccine for Humans Revenue Market Share by Country (2020-2031)

Figure 22. U.S. Rabies Vaccine for Humans Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 23. Canada Rabies Vaccine for Humans Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Europe Rabies Vaccine for Humans Sales Market Share by Country (2020-2031)

Figure 25. Europe Rabies Vaccine for Humans Revenue Market Share by Country (2020-2031)

Figure 26. Germany Rabies Vaccine for Humans Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. France Rabies Vaccine for Humans Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. U.K. Rabies Vaccine for Humans Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Italy Rabies Vaccine for Humans Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Russia Rabies Vaccine for Humans Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Rabies Vaccine for Humans Sales Market Share by Region (2020-2031)

Figure 32. Asia Pacific Rabies Vaccine for Humans Revenue Market Share by Region (2020-2031)

Figure 33. China Rabies Vaccine for Humans Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Japan Rabies Vaccine for Humans Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. South Korea Rabies Vaccine for Humans Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. India Rabies Vaccine for Humans Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Australia Rabies Vaccine for Humans Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. China Taiwan Rabies Vaccine for Humans Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Indonesia Rabies Vaccine for Humans Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Thailand Rabies Vaccine for Humans Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Malaysia Rabies Vaccine for Humans Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Rabies Vaccine for Humans Sales Market Share by Country (2020-2031)

Figure 43. Latin America Rabies Vaccine for Humans Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Rabies Vaccine for Humans Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Rabies Vaccine for Humans Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Rabies Vaccine for Humans Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Rabies Vaccine for Humans Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Rabies Vaccine for Humans Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Rabies Vaccine for Humans Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Rabies Vaccine for Humans Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Rabies Vaccine for Humans Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Rabies Vaccine for Humans by Type (2020-2031)

Figure 53. Global Revenue Market Share of Rabies Vaccine for Humans by Type (2020-2031)

Figure 54. Global Rabies Vaccine for Humans Price (USD/Unit) by Type (2020-2031)

Figure 55. Global Sales Market Share of Rabies Vaccine for Humans by Application (2020-2031)

Figure 56. Global Revenue Market Share of Rabies Vaccine for Humans by Application (2020-2031)

Figure 57. Global Rabies Vaccine for Humans Price (USD/Unit) by Application (2020-2031)

Figure 58. Rabies Vaccine for Humans Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions